LivingGLP1
Study S001330

GLP-1 Receptor Agonist-Induced Muscle Mass Evaluation and Retention

ClinicalTrials.gov record

Registration

Registration
NCT07272837
Acronym
GLIMMER
Study type
OBSERVATIONAL
Status
RECRUITING
Enrollment
50
Start
2026-05-15
Primary completion
2027-12-31
Lead sponsor
University of Alberta
Conditions
Type 2 Diabetes; Obesity; Semaglutide; GLP-1; Diabetes
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Changes in skeletal and cardiac muscle mass [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.